Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 502110011

CPC Scientific H-Thr-Arg-Ser-Ala-Trp-Leu-Asp-Ser-Gly-Val-Thr-Gly-Ser-Gly-Leu-Glu-Gly-Asp-His-Leu-Ser-Asp-Thr-Ser-Thr-Thr-Ser-Leu-Glu-Leu-Asp-Ser-Arg-OH (trifluoroacetate salt) 0.5MG
SDP

Catalog No. 502110011
Encompass

This peptide is the carboxyl-terminal fragment of pTHrP, which is a potent inhibitor of osteoclastic bone resorption. It is suggested that this product acts directly on osteoclasts.ONE-LETTER SEQUENCE: TRSAWLDSGVTGSGLEGDHLSDTSTTSLELDSRMOLECULAR FORMULA: C142H228N42O58MOLECULAR WEIGHT:3451.62STORAGE CONDITIONS: -20 5C, CAS REGISTRY NUMBER: [137348-10-8], RESEARCH AREA: OsteoporosisREFERENCES: A.J.Fenton et al., Endocrinology, 129, 1762 (1991); A.J.Fenton et al., Endocrinology, 129, 3424 (1991)

Catalog No. 50-211-0011 Supplier CPC Scientific Supplier No. OSTP008A
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

This peptide is the carboxyl-terminal fragment of pTHrP, which is a potent inhibitor of osteoclastic bone resorption. It is suggested that this product acts directly on osteoclasts.ONE-LETTER SEQUENCE: TRSAWLDSGVTGSGLEGDHLSDTSTTSLELDSRMOLECULAR FORMULA: C142H228N42O58MOLECULAR WEIGHT:3451.62STORAGE CONDITIONS: -20 5C, CAS REGISTRY NUMBER: [137348-10-8], RESEARCH AREA: OsteoporosisREFERENCES: A.J.Fenton et al., Endocrinology, 129, 1762 (1991); A.J.Fenton et al., Endocrinology, 129, 3424 (1991)

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.